Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo
- 9 July 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 319 (4), 1124-1131
- https://doi.org/10.1016/j.bbrc.2004.05.099
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)Oncogene, 2003
- Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemiaBlood, 2003
- The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoproteinBritish Journal of Pharmacology, 1999
- A phase I/II trial of paclitaxel for non-Hodgkinʼs lymphoma followed by paclitaxel plus quinine in drug-resistant diseaseAnti-Cancer Drugs, 1998
- Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquineBiochemical Pharmacology, 1996
- Effects of modulators of multidrug resistance on the expression of the MDR1 gene in human KB cells in cultureAnti-Cancer Drugs, 1996
- Major vault protein LRP-related multidrug resistanceEuropean Journal Of Cancer, 1996
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparumNature, 1990
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983